Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 306.89M | 205.10M | 81.46M | 96.15M | 432.28M |
| Total Depreciation and Amortization | 200.82M | -- | 385.72M | -180.26M | 188.99M |
| Total Amortization of Deferred Charges | 22.56M | -- | 46.21M | -24.42M | 13.61M |
| Total Other Non-Cash Items | 498.59M | -351.16M | 480.97M | -222.50M | 322.59M |
| Change in Net Operating Assets | -225.97M | -- | -457.70M | 521.11M | -515.82M |
| Cash from Operations | 802.88M | -146.06M | 536.66M | 190.09M | 441.65M |
| Capital Expenditure | -52.04M | -99.40M | -100.67M | -68.13M | -54.57M |
| Sale of Property, Plant, and Equipment | 9.51M | 15.38M | 3.56M | 1.77M | 7.55M |
| Cash Acquisitions | -- | -- | 53.04M | -4.13M | -84.09M |
| Divestitures | 0.00 | 378.60K | 2.27M | 1.01M | 134.60K |
| Other Investing Activities | 142.60M | 42.15M | -408.46M | 132.35M | 94.01M |
| Cash from Investing | 100.06M | -41.49M | -450.27M | 62.87M | -36.97M |
| Total Debt Issued | 15.08B | 23.21B | 13.30B | 14.29B | 18.72B |
| Total Debt Repaid | -16.11B | -22.12B | -18.29B | -16.22B | -18.09B |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -46.83M | -97.68M | -60.07M | -211.57M | -62.58M |
| Other Financing Activities | 246.69M | -256.98M | 316.91M | -867.35M | -287.70M |
| Cash from Financing | -161.88M | 22.04M | -719.16M | -601.75M | -15.33M |
| Foreign Exchange rate Adjustments | -28.40K | -1.27M | 1.18M | 323.90K | -2.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 741.03M | -166.78M | -631.59M | -348.47M | 386.89M |